Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk of Delayed Percutaneous Coronary Intervention for STEMI in the Southeast United States

Maxwell C. Messinger, View ORCID ProfileNicklaus P. Ashburn, Joshua S. Chait, Anna C. Snavely, Siena Hapig-Ward, View ORCID ProfileJason P. Stopyra, View ORCID ProfileSimon A. Mahler
doi: https://doi.org/10.1101/2024.07.11.24310307
Maxwell C. Messinger
1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
2Department of Family Medicine and Community Health, UMass Chan School of Medicine, Worcester, MA, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Maxwell.messinger3{at}umassmed.edu
Nicklaus P. Ashburn
1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicklaus P. Ashburn
Joshua S. Chait
1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
3Department of Surgery, Atrium Health Carolinas Medical Center, Charlotte, NC, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna C. Snavely
1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
4Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siena Hapig-Ward
1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
5Department of Emergency Medicine, University of California San Francisco Fresno School of Medicine, Fresno, CA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason P. Stopyra
1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jason P. Stopyra
Simon A. Mahler
1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
6Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA
7Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon A. Mahler
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Emergent reperfusion by percutaneous coronary intervention (PCI) within 90 minutes of first medical contact (FMC) is indicated in patients with ST-segment elevation myocardial infarction (STEMI). However, long transport times in rural areas in the Southeast US make meeting this goal difficult. The objective of this study was to determine the number of Southeast US residents with prolonged transport times to the nearest 24/7 primary PCI (PPCI) center.

Methods A cross-sectional study of residents in the Southeastern US was conducted based on geographical and 2022 5-Year American Community Survey data. The geographic information system (GIS) ArcGIS Pro was used to estimate Emergency Medical Services (EMS) transport times for Southeast US residents to the nearest PPCI center. All 24/7 PPCI centers in North Carolina, South Carolina, Georgia, Florida, Mississippi, Alabama, and Tennessee were included in the analysis, as well as nearby PPCI centers in surrounding states. To identify those at risk of delayed FMC-to-device time, the primary outcome was defined as a >30-minute transport time, beyond which most patients would not have PCI within 90 minutes. A secondary outcome was defined as transport >60 minutes, the point at which FMC-to-device time would be >120 minutes most of the time. These cutoffs are based on national median EMS scene times and door-to-device times.

Results Within the Southeast US, we identified 62,880,528 residents and 350 PPCI centers. Nearly 11 million people living in the Southeast US reside greater than 30 minutes from a PPCI center (17.3%, 10,866,710, +/- 58,143), with 2% (1,271,522 +/- 51,858) living greater than 60 minutes from a PPCI hospital. However, most patients reside in short transport zones; 82.7% (52,013,818 +/- 98,741). Within the Southeast region, 8.4% (52/616) of counties have more than 50% of their population in a long transport zone and 42.3% (22/52) of those have more than 90% of their population in long transport areas.

Conclusions Nearly 11 million people in the Southeast US do not have access to timely PCI for STEMI care. This disparity may contribute to increased morbidity and mortality.

Competing Interest Statement

Dr. Ashburn receives funding from NHLBI (K23HL169929) and AHRQ (R01HS029017). Dr. Snavely receives funding from Abbott Laboratories, NHLBI (K23HL169929), HRSA (1H2ARH399760100), and AHRQ (R01HS029017 and R21HS029234). Dr. Stopyra receives research funding from NCATS/NIH (KL2TR001421), HRSA (H2ARH39976-01-00), Roche Diagnostics, Abbott Laboratories, Pathfast, Genetesis, Cytovale, Forest Devices, Vifor Pharma, and Chiesi Farmaceutici. Dr. Mahler receives funding/support from Roche Diagnostics, Abbott Laboratories, QuidelOrtho, Siemens, Grifols, Pathfast, Beckman Coulter, Genetesis, Cytovale, National Foundation of Emergency Medicine, BlueJay Diagnostics. Duke Endowment, Brainbox, HRSA (1H2ARH399760100), and AHRQ (R01HS029017 and R21HS029234). He is a consultant for Roche, QuidelOrtho, Abbott, Siemens, Inflammatix, and Radiometer and is the Chief Medical Officer for Impathiq Inc.

Funding Statement

No funding was received for this project.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Wake Forest University School of Medicine Institutional Review Board 8th Floor, Hanes Building 1 Medical Center Boulevard Winston-Salem, North Carolina, 27157 Phone: 336-716-4542

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable

Data Availability

Data and R script used for analysis available from the corresponding author upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted July 12, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Risk of Delayed Percutaneous Coronary Intervention for STEMI in the Southeast United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Risk of Delayed Percutaneous Coronary Intervention for STEMI in the Southeast United States
Maxwell C. Messinger, Nicklaus P. Ashburn, Joshua S. Chait, Anna C. Snavely, Siena Hapig-Ward, Jason P. Stopyra, Simon A. Mahler
medRxiv 2024.07.11.24310307; doi: https://doi.org/10.1101/2024.07.11.24310307
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Risk of Delayed Percutaneous Coronary Intervention for STEMI in the Southeast United States
Maxwell C. Messinger, Nicklaus P. Ashburn, Joshua S. Chait, Anna C. Snavely, Siena Hapig-Ward, Jason P. Stopyra, Simon A. Mahler
medRxiv 2024.07.11.24310307; doi: https://doi.org/10.1101/2024.07.11.24310307

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Emergency Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)